Cargando…
Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis—Impact of Valve Size in a Single Center Experience
AIMS: The third generation Edwards Sapien 3 (Edwards Lifesciences Inc., Irvine, California) system was optimized to reduce residual aortic regurgitation and vascular complications. METHODS AND RESULTS: 235 patients with severe symptomatic aortic stenosis were prospectively enrolled. Transcatheter ao...
Autores principales: | Wöhrle, Jochen, Gonska, Birgid, Rodewald, Christoph, Seeger, Julia, Scharnbeck, Dominik, Rottbauer, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803290/ https://www.ncbi.nlm.nih.gov/pubmed/27003573 http://dx.doi.org/10.1371/journal.pone.0151247 |
Ejemplares similares
-
Noninvasive pacing during transfemoral implantation of the Edwards SAPIEN valve for tricuspid valve bioprosthesis stenosis
por: Demkow, Marcin, et al.
Publicado: (2016) -
Transcatheter Aortic and Mitral Valve‐in‐Valve Implantation Using the Edwards Sapien 3 Heart Valve
por: Shivaraju, Anupama, et al.
Publicado: (2018) -
Larger Valve Size is Associated with Permanent Pacemaker Implantation in Edwards SAPIEN 3™ Transcatheter Aortic Valves
por: Ahmad, Mansoor, et al.
Publicado: (2019) -
Influence of permanent pacemaker implantation after transcatheter aortic valve implantation with new-generation devices
por: Gonska, B., et al.
Publicado: (2018) -
The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature
por: Holoshitz, Noa, et al.
Publicado: (2012)